Send us a Message



 Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap)  (beta) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer) Overgo Probe Designer
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease COVID-19 Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models   new Genetic Models Autism Models PhenoMiner (Quantitative Phenotypes) Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes GERRC (Gene Editing Rat Resource Center) Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Poster Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources

CLINICAL MEASUREMENT - ANNOTATIONS

The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (http://rgd.mcw.edu/contact/index.shtml).
Term:endometrioid carcinoma incidence/prevalence measurement
go back to main search page
Accession:CMO:0001758 term browser browse the term
Definition:Any measurement in which the number of individuals in a study population that display endometrioid carcinoma at a point in time or develop endometrioid carcinoma within a determined period of time are compared to the total number of individuals in the study population. Often expressed as a percentage but could be expressed as a ratio. Endometrioid carcinoma is a malignant new growth occurring in the uterine fundus and ovaries and characterized by glandular patterns resembling those of the endometrium, which is made up of epithelial cells tending to infiltrate surrounding tissues and to give rise to metastases.
Synonyms:xref: MESH:D018269


show annotations for term's descendants           Sort by:
percentage of study population developing endometrioid carcinoma during a period of time term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Edcs1 Endometrial carcinoma susceptibility QTL1 IDA RGD PMID:11745480 RGD:1599856 NCBI chr11:18,976,208...24,697,116 JBrowse link
Q Edcs2 Endometrial carcinoma susceptibility QTL2 IDA RGD PMID:11745480 RGD:1599856 NCBI chr12:6,833,190...17,870,186 JBrowse link
Q Edcs3 Endometrial carcinoma susceptibility QTL3 IDA RGD PMID:11745480 RGD:1599856 NCBI chr20:1...25,159,026 JBrowse link
Q Edcs4 Endometrial carcinoma susceptibility QTL 4 IDA RGD PMID:11745480 RGD:1599856 NCBI chr 1:206,081,677...251,081,677 JBrowse link
Q Edcs5 Endometrial carcinoma susceptibility QTL 5 IDA RGD PMID:11745480 RGD:1599856 NCBI chr17:57,246,723...70,852,846 JBrowse link
Term paths to the root